Charles J. Parker

4.5k total citations
99 papers, 3.4k citations indexed

About

Charles J. Parker is a scholar working on Immunology, Hematology and Physiology. According to data from OpenAlex, Charles J. Parker has authored 99 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 40 papers in Hematology and 22 papers in Physiology. Recurrent topics in Charles J. Parker's work include Complement system in diseases (41 papers), Blood groups and transfusion (21 papers) and Erythrocyte Function and Pathophysiology (13 papers). Charles J. Parker is often cited by papers focused on Complement system in diseases (41 papers), Blood groups and transfusion (21 papers) and Erythrocyte Function and Pathophysiology (13 papers). Charles J. Parker collaborates with scholars based in United States, Japan and Canada. Charles J. Parker's co-authors include Wendell F. Rosse, M H Holguin, Nicole J. Bernshaw, Alfred K. Cheung, LA Wilcox, Jarmila Janatova, Josef T. Prchal, Ronald P. Taylor, Perumal Thiagarajan and Gregory T. Spear and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Charles J. Parker

98 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles J. Parker United States 36 1.8k 1.1k 708 564 485 99 3.4k
Otto Götze Germany 46 4.2k 2.3× 1.4k 1.3× 667 0.9× 699 1.2× 1.3k 2.6× 132 6.4k
Lise Halbwachs‐Mecarelli France 33 2.9k 1.6× 914 0.8× 966 1.4× 494 0.9× 1.2k 2.5× 75 5.1k
Henrik Sengeløv Denmark 36 2.2k 1.2× 1.4k 1.3× 681 1.0× 600 1.1× 1.9k 3.9× 149 6.2k
William P. Kolb United States 34 2.0k 1.1× 660 0.6× 233 0.3× 619 1.1× 773 1.6× 71 3.3k
Maciej M. Markiewski United States 36 2.6k 1.4× 503 0.5× 266 0.4× 297 0.5× 1.3k 2.6× 69 4.9k
Irma Gigli United States 40 3.1k 1.7× 1.6k 1.4× 219 0.3× 559 1.0× 1.2k 2.5× 131 5.9k
Russell P. Rother United States 34 4.7k 2.6× 2.4k 2.1× 2.0k 2.9× 658 1.2× 989 2.0× 72 7.9k
Philip E. Hass United States 24 2.1k 1.1× 1.7k 1.6× 162 0.2× 273 0.5× 1.8k 3.8× 36 5.6k
Edward N. Harris United States 45 1.3k 0.7× 2.5k 2.3× 899 1.3× 248 0.4× 1.7k 3.5× 123 7.8k
Margaret J. Polley United States 27 2.0k 1.1× 1.3k 1.1× 82 0.1× 508 0.9× 839 1.7× 52 3.7k

Countries citing papers authored by Charles J. Parker

Since Specialization
Citations

This map shows the geographic impact of Charles J. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles J. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles J. Parker more than expected).

Fields of papers citing papers by Charles J. Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles J. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles J. Parker. The network helps show where Charles J. Parker may publish in the future.

Co-authorship network of co-authors of Charles J. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Charles J. Parker. A scholar is included among the top collaborators of Charles J. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles J. Parker. Charles J. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benefield, Russell J, et al.. (2025). Platelet response following dexamethasone in obese vs nonobese patients with primary, acute immune-mediated thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 9(3). 102844–102844.
2.
Barton, James C., Wen‐Pin Chen, Mary J. Emond, et al.. (2016). GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. Blood Cells Molecules and Diseases. 63. 15–20. 12 indexed citations
3.
Parker, Charles J.. (2012). Paroxysmal nocturnal hemoglobinuria. Current Opinion in Hematology. 19(3). 141–148. 45 indexed citations
5.
Parker, Charles J., Robert A. Brodsky, & John E. Levine. (2009). Treatment versus Transplant for Challenging Hematologic Disorders. Biology of Blood and Marrow Transplantation. 15(1). 72–78. 3 indexed citations
6.
Dunn, Daniel E., et al.. (1999). Research directions in paroxysmal nocturnal hemoglobinuria. Immunology Today. 20(4). 168–171. 12 indexed citations
7.
Saifuddin, Mohammed, Charles J. Parker, Mark E. Peeples, et al.. (1995). Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.. The Journal of Experimental Medicine. 182(2). 501–509. 201 indexed citations
8.
Saifuddin, Mohammed, et al.. (1994). Host Cell Components Affect the Sensitivity of HIV Type 1 to Complement-Mediated Virolysis. AIDS Research and Human Retroviruses. 10(7). 829–837. 49 indexed citations
9.
Cheung, Alfred K., et al.. (1993). β2 integrins are required for neutrophil degranulation inducedby hemodialysis membranes. Kidney International. 43(3). 649–660. 28 indexed citations
10.
Parker, Charles J., et al.. (1993). Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A.. The Journal of Immunology. 151(6). 3308–3323. 12 indexed citations
11.
Wilson, B D, et al.. (1993). Regulation of endothelial cell protein c activation and fibrinolysis by procoagulant albumin. Thrombosis Research. 70(6). 459–469. 4 indexed citations
12.
Bohnsack, John F., et al.. (1992). Bacterial Evasion of the Antibody Response: Human IgG Antibodies Neutralize Soluble But Not Bacteria-Associated Group B Streptococcal C5a-ase. The Journal of Infectious Diseases. 165(2). 315–321. 10 indexed citations
13.
Holguin, M H & Charles J. Parker. (1992). Membrane Inhibitor of Reactive Lysis. Current topics in microbiology and immunology. 178. 61–85. 30 indexed citations
14.
Parker, Charles J.. (1992). Membrane Defenses Against Attack by Complement and Perforins. Current topics in microbiology and immunology. 178. 1–184. 15 indexed citations
15.
Bohnsack, John F., Xiaoning Zhou, Phillip Williams, et al.. (1991). Purification of the proteinase from group B streptococci that inactivates human C5a. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1079(2). 222–228. 20 indexed citations
16.
Cheung, Alfred K., et al.. (1990). Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney International. 37(4). 1055–1059. 122 indexed citations
17.
Parker, Charles J., O L Stone, & Nicole J. Bernshaw. (1989). Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.. The Journal of Immunology. 142(1). 208–216. 9 indexed citations
18.
Whatley, Ralph E., Martyn Lewis, Guy A. Zimmerman, et al.. (1988). The Regulation of Synthesis of Platelet-activating Factor by Endothelial Cells. CHEST Journal. 93(3). 110S–111S. 1 indexed citations
19.
Hill, Harry R., et al.. (1988). Group B streptococci inhibit the chemotactic activity of the fifth component of complement.. The Journal of Immunology. 141(10). 3551–3556. 57 indexed citations
20.
Parker, Charles J., et al.. (1965). The effect of carnosine on myofibrillar ATPase activity. Biochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation. 110(1). 212–214. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026